Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedCore content updated: new operating-status notice and latest version (v3.2.0) added; older version tag removed and a specific item (Adrenal cortex carcinoma) deleted.SummaryDifference3%
- Check24 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page updated from v3.0.1 to v3.0.2 and removed the 'Back to Top' element, indicating a minor revision with no evident core-content changes.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new related topics on adrenal gland cancer, while several previous terms and drug information have been removed.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.4%
Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.